Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Scheper

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|November 20, 2014
Link between co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system could be due to confoundingHenk Scheper, Willem M Lijfering
Expert Review of Anti-Infective Therapy|May 4, 2023
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?Marjan Wouthuyzen-Bakker, Henk Scheper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2021
Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?Henk Scheper, Mark G J De Boer
Journal of Bone and Joint Infection|September 28, 2020
Comment on "Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France" by Becker et al. (2020)Henk Scheper, Mark G J de Boer
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2015
[Invasive pulmonary aspergillosis in influenza]Eva Kolwijck, Henk Scheper, Judith Beuving, et al.
The European Respiratory Journal|August 4, 2018
Tuberculosis after a borderline QuantiFERON result during screening before infliximabJonathan W Uzorka, Nathalie M Delfos, Anne M C Witte, et al.
Bone & Joint Open|October 1, 2021
Modular component exchange and outcome of DAIR for hip and knee periprosthetic joint infection : a systematic review and meta-regression analysisMaxime Gerritsen, Abdullah Khawar, Henk Scheper, et al.
JB & JS Open Access|February 24, 2025
Periprosthetic Joint Infection Surrounding Lower-Extremity Endoprostheses After Tumor Resection: Causative Microorganisms, Effectiveness of DAIR, and Risk Factors for Treatment FailurePhilip Sanders, Henk Scheper, Robert van der Wal, et al.
Surgery in Practice and Science|January 23, 2025
Outcome of debridement, antibiotics and implant retention for streptococcal hip and knee prosthetic joint infections: A systematic review and meta-analysisLaura M Gerritsen, Henk Scheper, Mark G J de Boer, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 24, 2019
[Prosthetic joint infection]Henk Scheper, Marjan Wouthuyzen-Bakker, Karin Ellen Veldkamp, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|November 20, 2014
Link between co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system could be due to confoundingHenk Scheper, Willem M Lijfering
Expert Review of Anti-Infective Therapy|May 4, 2023
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?Marjan Wouthuyzen-Bakker, Henk Scheper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2021
Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?Henk Scheper, Mark G J De Boer
Journal of Bone and Joint Infection|September 28, 2020
Comment on "Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France" by Becker et al. (2020)Henk Scheper, Mark G J de Boer
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2015
[Invasive pulmonary aspergillosis in influenza]Eva Kolwijck, Henk Scheper, Judith Beuving, et al.
The European Respiratory Journal|August 4, 2018
Tuberculosis after a borderline QuantiFERON result during screening before infliximabJonathan W Uzorka, Nathalie M Delfos, Anne M C Witte, et al.
Bone & Joint Open|October 1, 2021
Modular component exchange and outcome of DAIR for hip and knee periprosthetic joint infection : a systematic review and meta-regression analysisMaxime Gerritsen, Abdullah Khawar, Henk Scheper, et al.
JB & JS Open Access|February 24, 2025
Periprosthetic Joint Infection Surrounding Lower-Extremity Endoprostheses After Tumor Resection: Causative Microorganisms, Effectiveness of DAIR, and Risk Factors for Treatment FailurePhilip Sanders, Henk Scheper, Robert van der Wal, et al.
Surgery in Practice and Science|January 23, 2025
Outcome of debridement, antibiotics and implant retention for streptococcal hip and knee prosthetic joint infections: A systematic review and meta-analysisLaura M Gerritsen, Henk Scheper, Mark G J de Boer, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 24, 2019
[Prosthetic joint infection]Henk Scheper, Marjan Wouthuyzen-Bakker, Karin Ellen Veldkamp, et al.
Pageof 3